Software solutions in spaces from real estate to healthcare announced fresh capital raises last week. Find out which companies are building out their tech platforms with the Built In NYC Weekly Refresh.
Sourcemap pulled in $20M. Energize Ventures led the Series B funding round for Sourcemap, a company that equips manufacturers and brands with supply chain mapping and monitoring solutions. Its latest round of capital will go toward expanding its global footprint and adding new solutions to its suite of software products. [PRNewswire]
Amogy secured $11M. Adding onto its previously announced Series B round, clean energy tech provider Amogy has brought its latest raise to $150 million total. With the new capital from Marunouchi Climate Tech Growth Fund and others, Amogy plans to support commercialization and begin manufacturing its product, with the goal of bringing its tech to market in 2024. [PRNewswire]
NYC Tech Quote of the Week
“We started this company with the vision of using the most advanced technology to transform the industries fundamental to our lives. We are incredibly proud of the change we have driven in the real estate industry over the last 6 years. We are thrilled to bring on new partners to enable us to continue to innovate and push into new markets.” — Minna Song, co-founder and CEO of EliseAI
EliseAI raised $35M. Operating within the real estate industry, EliseAI developed a generative AI platform that automates conversations between renters and apartment building owners. The company plans to expand its tech into new markets following this Series C funding round from lead investor Point72. [EliseAI]
Yuvo Health secured $20.2M. Working to bring quality healthcare to underserved communities, Yuvo Health provides community health centers with a tech-enabled administrative and managed-care platform. Backed by Mastry Ventures for its Series A funding round, Yuvo Health will scale its infrastructure and expand into Ohio. [PR Newswire]
In more VC funding news: Alternative meat producer MyForest Food pulled in $15 million in Series A-2 funding to distribute its first mushroom mycelium-based product, MyBacon. [AgFunder Networks]
Mend, a life sciences and digital health company, pulled in a $15 million Series A round led by S2G Ventures to execute existing provider contracts and scale nationwide. [PRNewswire]
